Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives
Vivien C Abad Department of Psychiatry & Behavioral Sciences, Division of Sleep Medicine, Stanford University, Redwood City, CA 94063, USACorrespondence: Vivien C AbadDepartment of Psychiatry & Behavioral Sciences Division of Sleep Medicine, Stanford University Outpatient Center, 450...
Saved in:
Main Author: | Abad VC |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/629dd71a3da84861a4f3bfc25de85b27 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects
by: Sahni AS, et al.
Published: (2019) -
Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility
by: Guevarra JT, et al.
Published: (2020) -
Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients
by: Talih FR, et al.
Published: (2017) -
Occupational Outcomes Associated with Sleep Quality and Excessive Daytime Sleepiness: Results from a National Survey
by: AlShareef SM
Published: (2020) -
Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
by: Vellieux G, et al.
Published: (2021)